|
 |
PexevaThis page contains recent news articles, when available, and an overview of Pexeva but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.Its key products include Vivelle-Dot, CombiPatch, Estradot, Estalis, Stavzor, Pexeva, Lithobid and Daytrana. The company is The Noven Pharmaceuticals, ... PR-Inside.com (Pressemitteilung) Noven to Buy Drugmaker JDS - Jul 10, 2007 JDS markets two prescription psychiatry products, Pexeva and Lithobid, and has a pipeline of psychiatry and women's health treatments that includes one ... TheStreet.com - TheStreet.com (subscription) Alpharma and Synthon to co-promote Pexeva.(Brief Article) - Jan 24, 2005 US firms Alpharma and Synthon Pharmaceuticals have announced that the former's sales force will co-promote the latter's Pexeva (paroxetine; first marketed ... Free with registration - Pharma Marketletter - AccessMyLibrary.com Despite recall charges, Noven flips to profit - Nov 6, 2008 ...of operating income after the company eliminated a previous liability related to sales of Pexeva, a depression and panic disorder medication. ... Bizjournals.com Alpharma and Synthon Pharmaceuticals Announce Co-Promotion … - Jan 13, 2005 Pexeva(TM) is a branded selective serotonin reuptake inhibitor for the treatment of depression, obsessive/compulsive disorder, and/or panic disorder. ... Free with registration - PR Newswire - AccessMyLibrary.com New and generic drug approvals: Pexeva (paroxetine mesylate) Tablets. - Dec 13, 2006 On 13 Dec 2006, the US Food and Drug Administration announced approval (new or modified indication) of NDA 021299 for Pexeva (paroxetine mesylate) Tablets. ... Pay-Per-View - US Food and Drug Administration News - Factiva, from Dow Jones BWR Begins Tracking Noven Pharmaceuticals Inc. - Jul 11, 2007 Noven said it expects sales of JDS drugs Pexeva (an antidepressant indicated for major depressive disorder, panic disorder, obsessive-compulsive disorder ... Free with registration - M2 Presswire - AccessMyLibrary.com Collaborations; Pharmaceutical companies announce promotion … - Feb 8, 2005 Pexeva is a branded selective serotonin reuptake inhibitor for the treatment of depression, obsessive/compulsive disorder, and/or panic disorder. ... Pay-Per-View - Life Science Weekly - Factiva, from Dow Jones Press Release: JDS Pharmaceuticals and Synthon Pharmaceuticals … - Feb 7, 2005 Alpharma to Promote Pexeva(TM) in Addition to Kadian(R) Alpharma Inc. and ... Synthon Pharmaceuticals has developed Pexeva, a generic version priced much ... Pay-Per-View - PR Newswire - HighBeam Research Noven Announces 2008 Second Quarter Financial Results - Aug 6, 2008 This increase reflects the addition of $6.6 million in Pexeva(R) and Lithobid(R) product sales through Noven Therapeutics, as well as increased license and ... RedOrbit Press Release: Alpharma and Synthon Pharmaceuticals Announce Co- … - Jan 13, 2005 Pexeva(TM) is a branded selective serotonin reuptake inhibitor for the treatment of depression, obsessive/compulsive disorder, and/or panic disorder. ... Pay-Per-View - PR Newswire - HighBeam Research More than skin deep: Robert Strauss makes a $125 million investment … - Oct 1, 2007 JDS has two brand-name prescription pills (Lithobid and Pexeva), to treat bipolar disorder and depression respectively, on the market currently. ... Free with registration - South Florida CEO - AccessMyLibrary.com Press Release: KADIAN(R) (morphine sulfate extended-release) … - May 4, 2006 Since patients experiencing pain often suffer from depression, Kadian(R) and Pexeva(TM ... psychiatry and will allow more patients to benefit from Pexeva ... Pay-Per-View - PR Newswire - HighBeam Research Psychotherapy, social support essential to treat depression: evidence... - Oct 1, 2007 10 mg/5 mL PO susp controlled release - 12.5, 25, 37.5 12.5-25 mg once Paxil CR mg tabs Paroxetine mesylate - 10, 20, 30, 10 mg once Pexeva (Synthon) 40 ... $4.95 - Managed Healthcare Executive - ECNext Press Release: FDA Approves Alpharma's KADIAN(R) New 10mg … - Apr 23, 2007 Alpharma to Promote Pexeva(TM) in Addition to Kadian(R) Alpharma Inc. and Synthon Pharmaceuticals ... often suffer from depression, Kadian(R) and Pexeva(TM) ... Pay-Per-View - PR Newswire - HighBeam Research Insurer urges pill-splitting to ease swollen expenses - Jun 4, 2006 ...the Angiotensin Receptor Blockers Atacand, Avapro, Benicar, Cozaar and Diovan; the antidepressants Lexapro, Pexeva and Zoloft and the antiviral Valtrex. ... Pay-Per-View - Chicago Tribune - ProQuest Archiver Leading Insurer Pushes Splitting Pills - Jun 11, 2005 ANTIDEPRESSANTS: Lexapro, Pexeva, Zoloft. CHOLESTEROL DRUGS: Crestor, Lipitor, Zocor, Pravachol. ANTIVIRAL: Valtrex. The Associated Press ... Pay-Per-View - Tampa Tribune - ProQuest Archiver It's hard for the drug companies to swallow, but pill-splitting saves... - Mar 14, 2006 ...depression; Lipitor, high cholesterol; Mavik, hypertension; Paxil, depression; Pexeva, depression; Pravachol, high cholesterol; Valtrex, herpes; Viagra, ... $2.95 - Buffalo News - NewsBank Breakup with Paxil hard to do - Apr 17, 2007 What it is: Paxil, also known as Paroxetine, Seroxat, Aeropax, Apo-paroxetine, Apotex, Pexeva, is a prescription antidepressant. Rocky Mountain News Synthon, Pfizer in legal wrangle - Jan 28, 2005 In January 2004, Synthon announced it had reached a settlement that threw out GSK's patent and royalty claims and allowed Synthon to begin selling Pexeva. ... Bizjournals.com Noven Announces Final FDA Approval of Stavzor(TM) for the Treatment... - Jul 30, 2008 ...consisting of Pexeva(R) (paroxetine mesylate) for the treatment of depression, generalized anxiety disorder, obsessive/compulsive disorder and panic ... Genetic Engineering News - Genetic Engineering News (press release) Boston Globe, The : Noven - Jul 11, 2007 The acquisition will include two products already being sold - Lithobid, for bipolar disorder, and Pexeva, for depression - and four with potential to reach ... $2.95 - Boston Globe - NewsBank Noven Appoints Peter C. Brandt As President, Chief Executive Officer... - Apr 29, 2008 Oral products currently offered through the Noven marketing and sales infrastructure consist of Pexeva® (paroxetine mesylate) and Lithobid® (lithium ... Lifescience-online Noven Announces 2007 Financial Results - Mar 27, 2008 During the year, we also completed the acquisition of JDS Pharmaceuticals, now Noven Therapeutics, which currently sells the oral products Pexeva(R) and ... Genetic Engineering News - Genetic Engineering News (press release) Noven Pharmaceuticals 3Q earnings top expectations, revenue misses - Nov 8, 2007 The company said the increase in revenue reflects the recognition of $3.3 million associated with sales of JDS's Pexeva and Lithobid products, higher sales ... ABCmoney.co.uk Pharmaceutical Industry Marketing and Sales Veteran to Lead Auriga's ... - Jan 4, 2006 He led the launch of Synthon's first branded drug, Pexeva(r) (paroxetine mesylate) into the SSRI depression market. Prior to this, Mr. Shales was marketing ... primezone.com Combination Strategy Works in Teens' Refractory Depression - Feb 26, 2008 They were randomized to switch to a different SSRI (20 to 40 mg of paroxetine [Paxil, Pexeva], citalopram [Celexa], or fluoxetine [Prozac]), switch to 150 ... MedPage Today FDA GIVES TENTATIVE APPROVAL OF STAVZOR. - Feb 1, 2008 Products currently marketed through the Noven/JDS sales infrastructure consist of Pexeva[R] (paroxetine mesylate) and Lithobid[R] (lithium carbonate). ... Entrepreneur PRESS RELEASE: Noven Pharmaceuticals's Lithium Product Fails to … - Oct 8, 2007 Products currently marketed through the JDS psychiatry sales infrastructure include Pexeva® (paroxetine mesylate) and Lithobid® (lithium carbonate). ... FierceBiotech FDA Safety Labeling Changes: CombiPatch, Antidepressants - Mar 23, 2005 It has also been included in the labeling for paroxetine mesylate tablets (Pexeva, made by Synthon Pharmaceuticals, Ltd.); mirtazapine orally disintegrating ... Medscape Link Between Antidepressants and Birth Defect - Nov 24, 2008 Sertraline (Zoloft) and citalopram (Celexa) were associated with a slightly higher incidence than fluoxetine (Prozac) and paroxetine (Paxil, Pexeva). ... PhysOrg.com Paroxetine Exposure in Early Pregnancy Linked to Risk of Defects - Dec 8, 2005 Paroxetine mesylate (Pexeva tablets, made by Synthon Pharmaceuticals, Ltd) is indicated for the treatment of MDD, OCD, and PD. ... Medscape Noven Amends Stockholder Rights Plan, Increasing Trigger Provision to... - Mar 18, 2008 Oral products currently offered through the Noven marketing and sales infrastructure consist of Pexeva(R) (paroxetine mesylate) and Lithobid(R) (lithium ... Genetic Engineering News - Genetic Engineering News (press release) Noven Announces FDA Tentative Approval of Stavzor(TM) Valproic Acid … - Dec 26, 2007 Products currently marketed through the Noven/JDS sales infrastructure consist of Pexeva® (paroxetine mesylate) and Lithobid® (lithium carbonate). ... RedOrbit Thioridazine Side Effects from Consumer Reports Health. - Jan 11, 2008 ...fluoxetine (Prozac, Sarafem), fluvoxamine (Luvox), moxifloxacin (Avelox), paroxetine (Paxil, Pexeva), pimozide (Orap), pindolol (Visken), procainamide, ... consumerreports.org Noven Announces Share Repurchase Program. - Sep 5, 2007 Products currently marketed through the JDS psychiatry sales infrastructure include Pexeva([R]) (paroxetine mesylate) and Lithobid([R]) (lithium carbonate). ... Free with registration - Business Wire - AccessMyLibrary.com CORRECTING and REPLACING Noven Announces First Quarter 2008 … - May 8, 2008 This increase reflects the addition of $5.7 million in Pexeva(R) and Lithobid(R) product sales, as well as increased license and contract revenues, ... Genetic Engineering News - Genetic Engineering News (press release) FDA Issues Approvable Letter for Stavzor(TM) Delayed Release Valproic... - Oct 23, 2007 Products currently marketed through the JDS psychiatry sales infrastructure include Pexeva([R]) (paroxetine mesylate) and Lithobid([R]) (lithium carbonate). ... Free with registration - Business Wire - AccessMyLibrary.com Factiva Search - Jan 24, 2005 Alpharma and Synthon to co-promote Pexeva.(Brief Article). 24 January, 2005 Pharma Marketletter. US firms Alpharma and Synthon Pharmaceuticals have ... Pay-Per-View - Pharma Marketletter - Factiva, from Dow Jones How to take Pimozide from Consumer Reports Health. - Jan 11, 2008 ...paroxetine (Paxil, Pexeva), and sertraline (Zoloft); tacrolimus (Prograf); thioridazine; zileuton (Zyflo); and ziprasidone (Geodon). ... consumerreports.org FDA OKs Antidepressant Labeling, Standardized Black Box Language - Feb 7, 2005 ...(chlordiazepoxide anamitriptyline HCl); Oxford's Marplan (isocarboxazid); Odyssey's Surmontil (trimipramine maleate); and Synthon's Pexeva (paroxetine). ... Pay-Per-View - Drug GMP Report - Factiva, from Dow Jones Noven Appoints Michael D. Price Chief Financial Officer - Nov 15, 2007 Products currently marketed through the Noven/JDS sales infrastructure consist of Pexeva(R) (paroxetine mesylate) and Lithobid(R) (lithium carbonate). ... Genetic Engineering News - Genetic Engineering News (press release) Noven Announces 2007 Third Quarter Earnings Release DateMIAMIFL- … - Feb 11, 2007 Products currently marketed through the JDS psychiatry sales infrastructure consist of Pexeva ® (paroxetine mesylate) and Lithobid ® (lithium carbonate). ... Ad-Hoc-News - Ad-Hoc-News (Pressemitteilung) Press Release: Boston, MA -- Form4Oracle: Insider Trading Report: … - Nov 26, 2008 The Noven Therapeutics segment?s products comprise Pexeva for depressive disorder, panic disorder, obsessive compulsive disorder, and generalized anxiety ... Pay-Per-View - M2 Presswire - HighBeam Research Noven to buy JDS Pharma in $125M deal. - Jul 16, 2007 ...of $400.0 million a year in that year, while Pexeva and Lithobid will recognize revenues of around $14.0 million in the second half of this year. ... Free with registration - Pharma Marketletter - AccessMyLibrary.com Press Release: It Is Expected That China's Lithium Carbonate Output... - Jul 21, 2008 M2 Presswire; April 29, 2008 ; 700+ words ... ... consist of Pexeva (paroxetine mesylate) and Lithobid (lithium carbonate). ... Pay-Per-View - M2 Presswire - HighBeam Research Press Release: Progressive Following on Noven Pharmaceuticals Inc. - ... - Mar 27, 2008 Oral products currently offered through the Noven marketing and sales infrastructure consist of Pexeva (paroxetine mesylate) and Lithobid (lithium ... Pay-Per-View - M2 Presswire - HighBeam Research Noven Reports Third Quarter 2007 Financial Results. - Nov 8, 2007 This increase reflects the recognition of $3.3 million in net revenues associated with sales of JDS's Pexeva([R]) and Lithobid([R]) products for the period ... $4.95 - Business Wire - ECNext US FDA to update black box warnings for young adults taking … - May 14, 2007 Norpramin (desipramine HCl); Pamelor (nortriptyline); Parnate (tranylcypromine sulfate);Paxil (paroxetine HCl); Pexeva (paroxetine mesylate); ... $9.94 - Pharma Marketletter - Alacra Store Noven Pharmaceuticals Inc. to Buy JDS Pharmaceuticals. - Jul 12, 2007 Noven said it expects sales of JDS drugs Pexeva (an antidepressant indicated for major depressive disorder, panic disorder, obsessive-compulsive disorder ... $4.95 - M2 Presswire - ECNext Press Release: Global and China Lithium Carbonate Industry Report … - Nov 3, 2008 M2 Presswire; April 29, 2008 ; 700+ words ... ... consist of Pexeva (paroxetine mesylate) and Lithobid (lithium carbonate). ... Pay-Per-View - M2 Presswire - HighBeam Research Press Release: Understand And Examine The Lithium Carbonate Market … - Oct 2, 2007 M2 Presswire; April 29, 2008 ; 700+ words ... ... consist of Pexeva (paroxetine mesylate) and Lithobid (lithium carbonate). ... Pay-Per-View - M2 Presswire - HighBeam Research Press Release: China Lithium Carbonate Market Forecast Report, 2008- … - Oct 1, 2007 M2 Presswire; April 29, 2008 ; 700+ words ... ... consist of Pexeva (paroxetine mesylate) and Lithobid (lithium carbonate). ... Pay-Per-View - M2 Presswire - HighBeam Research Noven Pharmaceuticals Inc.(The Industry) - Sep 1, 2007 Noven will gain JDS's specialty sales force, which currently markets Lithobid (lithium carbonate) for bipolar disorder and the antidepressant Pexeva ... $4.95 - Pharmaceutical Representative - ECNext Press Release: Noven Pharmaceuticals Inc. to buy JDS. - M2 Presswire... - Jul 11, 2007 New York-based JDS sells the branded prescription psychiatry drugs Lithobid and Pexeva, which are used to treat bipolar disorder and depression, ... Pay-Per-View - M2 Presswire - HighBeam Research JDS Pharmaceuticals.(The Community) - Aug 1, 2007 In his new" role, Briggs will focus on the marketing of Pexeva, as well as a new, unnamed product. He joined JDS in March of 2006. ... $4.95 - Pharmaceutical Representative - ECNext |
|
Health Home | Conditions | Cancer | Medications | Surgery | Vaccines The Cancer News Network
COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy |
